Literature DB >> 7895762

Valproate and cytochrome c oxidase deficiency.

S Ponchaut, F Van Hoof, K Veitch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7895762     DOI： 10.1007/bf01972980

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  4 in total

Review 1.  Valproate and mitochondria.

Authors:  S Ponchaut; K Veitch
Journal:  Biochem Pharmacol       Date:  1993-07-20       Impact factor: 5.858

2.  Effects of valproate on biogenesis and function of liver mitochondria.

Authors:  K Hayasaka; I Takahashi; Y Kobayashi; K Iinuma; K Narisawa; K Tada
Journal:  Neurology       Date:  1986-03       Impact factor: 9.910

3.  Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency.

Authors:  B Chabrol; J Mancini; D Chretien; P Rustin; A Munnich; N Pinsard
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

4.  Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration.

Authors:  S Ponchaut; F van Hoof; K Veitch
Journal:  Biochem Pharmacol       Date:  1992-02-04       Impact factor: 5.858
  4 in total
  2 in total

1.  Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.

Authors:  Chih-Ming Lin; Peterus Thajeb
Journal:  Metab Brain Dis       Date:  2007-01-17       Impact factor: 3.584

2.  The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.

Authors:  Marta Kanabus; Elisa Fassone; Sean David Hughes; Sara Farahi Bilooei; Tricia Rutherford; Maura O' Donnell; Simon J R Heales; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2016-04-14       Impact factor: 4.982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.